ThirdGate makes cornerstone investment in Zelira Therapeutics / HOPE 1 SPV

15 January 2026

ThirdGate Capital has made a cornerstone investment in Zelira Therapeutics / HOPE 1 SPV through the TGC Biotechnology Fund.

[Client to supply announcement copy.]